Argus Research Adjusts GE Healthcare Technologies PT to $85 From $80

Argus Research has increased its price target for GE Healthcare Technologies (GEHC) from $80 to $85, while maintaining a Buy rating on the stock. This adjustment follows the company's Q1 results which exceeded expectations and an increased adjusted EPS forecast for the year. The report highlights GE Healthcare's strong market position, innovative product pipeline, and growth opportunities in a defensive sector.